Effects of unprocessed and processed cardiopulmonary bypass blood retransfused into patients after cardiac surgery

International Journal of Artificial Organs

Volumn 22, Issue 4, 1999, Pages 210-216

  Walpoth, B H ^a   Eggensperger, N ^b   Hauser, S P ^c   Neidhart, P ^a   Kurt, G ^a   Spaeth, P J ^b   Althaus, U ^c  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

^b Central Laboratory in Bern   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Blood purification; Cardiac surgery; Cardiopulmonary bypass; Cell saver; Complement activation; Cytokines

Indexed keywords

BLOOD; CARDIOVASCULAR SURGERY; VENTILATION;

BLOOD PURIFICATION; CARDIAC-SURGERY; CARDIOPULMONARY BYPASS; CELL SAVER; CLINICAL OUTCOME; CLINICAL PARAMETERS; COMPLEMENT ACTIVATIONS; CONTROL GROUPS; CYTOKINES; PROSPECTIVE STUDY;

CHEMICAL ACTIVATION;

BLOOD CLOTTING FACTOR; COMPLEMENT COMPONENT C3A; D DIMER; HEMOGLOBIN; HEPARIN; INTERLEUKIN 6; INTERLEUKIN 8;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BLOOD AUTOTRANSFUSION; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CYTOKINE PRODUCTION; ERYTHROCYTE CONCENTRATE; FEMALE; HUMAN; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME;

EID: 0033043511     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139889902200406     Document Type: Article

References (19)

1. Zimmermann R, Büscher M, Linhardt G, et al. A survey of blood component use in a German university hospital. Transfusion 1997; 37:1075-83.
2. Dietrich W, Barankay A, Dilthey G, Mitto HP, Richter JA. Reduction of blood utilisation during myocardial revasculatisaion. J Thorac Cardiovasc Surg 1989; 97:213-9.
3. Walpoth BH, Schwaller J, Hofstetter H, Castelli D, Nydegger U. Current problems with autologous blood supply. Infusionsther Transfusionsmed 1993; 20: 316-26.
4. Winton TL, Charrette EJP, Salerno TA. The cell saver during cardiac surgery: Does it save? Ann Thorac Surg 1982; 33: 379-81.
5. Haan J, Boonstra PW, Monnink SH, Ebels T, van Oeveren W. Retransfusion of suctioned blood during cardiopulmonary bypass impairs hemostasis. Ann Thorac Surg 1995; 59:901-7.
6. Schonberger JPAM, van Oeveren W, Bredée JJ, Everts PAM, de Haan J. Wildevuur Ch. Systemic blood activation during and after autotransfusion. Ann Thorac Surg 1994; 57:1256-62.
7. Edmund LH, Jr. Blood-surface interactions during cardiopulmonary bypass. J Card Surg 1993; 8:404-10.
8. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonar bypass. Ann Thorac Surg 1993; 55:552-9.
9. Neuhof H, Soeparwata R, Neuhof C, Scheid HH. Zur pathophysiologischen Rolle von Zytokinen beim kardiopulmonalen Bypass. Infusionsther Transfusionsmed 1993; 23.
10. Mori F, Nakahara Y, Kurata S, Furukawa S, Esato K, Mohri H. Late changes in hemostatic parameters following open-heart surgery. J Cardiovasc Surg 1982; 23:458-62.
11. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86:845-7.
12. Kestin AS, Valeri CR, Khuri SF et al. The platelet function defect of cardiopulmonary bypass. Blood 1993; 82:107-17.
13. Khuri SF, Wolfe JA, Josa M et al. Hematologie changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss. J Thorac Cardiovasc Surg 1992; 104:94-107.
14. Moat NE, Shore DF, Evans TW. Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins. Eur J Cardiothorac Surg 1993:7:563-73.
15. Walpoth BH, Eggensperger N, Walpoth-Aslan BN, et al. Qualitative assessment of blood washing with the continuous autologous transfusion system (CATS). Int J Artif Organs 1997;20:234-9.
16. Gillinov AM, Redmond JM, Winkelstein JA et al. Complement and neutrophil activation during cardiopulmonary by-pass: A study in the complement-deficient dog. Ann Thorac Surg 1994:57:345-52.
17. Nagamine S, Tabayashi K, Haneda K, Mohri H. A clinical study of respiratory complication after cardiopulmonary bypass, with special reference to complement activation, WBC and granulocyte elastase. Nippon Geka Gakkai Zasshi 1994:95:348-53.
18. Walpoth BH, Amport T, Schmid R, et al. Hemofiltration during cardiopulmonary bypass: Quality assessment of hemoconcentrated blood. Thorac Cardiovasc Surg 1994; 42: 162-9.
19. Steinberg JB, Kapelanski DP, Oison JD, Weiler JM. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993; 106: 1008-15.